You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice

Authors

  • Michael John Zobel Division of Pediatric Surgery, Department of Surgery, Children’s Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Abigail K Zamora Division of Pediatric Surgery, Department of Surgery, Children’s Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Hong-wei Wu Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Jianping Sun Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Danny Lascano Division of Pediatric Surgery, Department of Surgery, Children’s Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Jemily Malvar Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Larry Wang Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Michael A Sheard Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Robert C Seeger Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Eugene S Kim Division of Pediatric Surgery, Department of Surgery, Children’s Hospital Los Angeles, Los Angeles, California, USA Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA PubMed articlesGoogle scholar articles

Citation

Zobel MJ, Zamora AK, Wu H, et al
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice
Journal for ImmunoTherapy of Cancer 2020;8:e001560. doi: 10.1136/jitc-2020-001560
Online issue publication 
December 18, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.